Is the US prepared to deal with another pandemic or widespread health crisis?

Evaluating whether the United States is prepared for another pandemic or widespread health crisis reveals a complex picture. While the U.S. possesses unprecedented medical technologies and scientific tools developed since COVID-19, its public health infrastructure, global surveillance networks, and institutional trust have experienced significant shifts and disruptions.

The consensus among public health experts, independent watchdogs, and policy analysts is that the U.S. remains highly vulnerable and, in several key areas, is less prepared to respond to a major outbreak than it was prior to 2020.

1. Shifted Institutional & Federal Landscape

Following the start of the second Trump administration in 2025, the federal approach to public health and pandemic preparedness underwent a major overhaul:

•HHS Leadership & Policy Priorities: Under Health and Human Services (HHS) Secretary Robert F. Kennedy Jr., the federal government has heavily prioritized addressing chronic diseases and environmental toxins through the "Make America Healthy Again" (MAHA) initiative. However, this shift has also come with deep skepticism toward traditional vaccine mandates, changes to federal advisory committees, and proposals to scale back infectious disease research.

•The White House Pandemic Office (OPPR): The Office of Pandemic Preparedness and Response Policy (OPPR), created by Congress in 2022 to coordinate cross-agency responses, sat empty and unstaffed for nearly a year after Biden-era staff departed and a previous director resigned. In July 2026, the administration partially restaffed the office, appointing Dr. Sara Brenner (a former FDA official aligned with the MAHA movement) to lead it, alongside Dr. Rachel Idowu as National Security Council (NSC) director for bioresponse. Critics note that the office remains vastly understaffed compared to its peak, leaving its capability to coordinate a massive interagency response in question.

•The WHO Withdrawal: On January 22, 2026, the United States formally finalized its withdrawal from the World Health Organization (WHO), terminating federal funding and recalling all personnel. Global health experts warn this is a critical blow to U.S. preparedness, as the U.S. no longer participates in the Global Influenza Surveillance and Response System (GISRS). This limits the nation’s access to real-time international pathogen data and viral samples, which are vital for formulating yearly flu shots and detecting early warning signs of global outbreaks.

2. State-Level Disparities & Funding Cuts

Domestic readiness varies drastically by geography. According to the Ready or Not 2026 report published by the nonpartisan Trust for America's Health (TFAH), state-level emergency preparedness is highly uneven:

•Only 20 states placed in the high-performance tier for emergency readiness, while 17 states (plus D.C.) were in the middle tier, and 13 states fell into the low-performance tier.

•Funding Cuts: Despite heightened biological threats, at least 12 states reduced their public health budgets. Additionally, federal funding cuts and administrative instability at the national level have trickled down, destabilizing local health departments and reducing the overall public health workforce.

3. Key Vulnerabilities

Experts identify several compounding weaknesses that would hamper the U.S. during a rapid-onset health crisis:

•The Trust Deficit and Misinformation: Public trust in institutions like the CDC and FDA remains severely fractured. Misinformation regarding treatments and vaccines continues to spread widely. Pockets of vaccine hesitancy have contributed to preventable domestic outbreaks, such as measles.

•Workforce Exhaustion and Brain Drain: The public health and healthcare sectors have suffered immense burnout since the COVID-19 pandemic. Many career epidemiologists, local health directors, and frontline medical workers have left the field, leaving a massive gap in institutional knowledge and crisis-response experience.

•Co-circulating Threats: The U.S. healthcare system already operates near capacity due to seasonal respiratory surges (influenza, COVID-19, and RSV). Concurrently, persistent threats such as H5N1 avian influenza in domestic dairy and bird populations, rare hantavirus cases, and global surges of Ebola stretch existing diagnostic and isolation resources.

4. Areas of Scientific and Technological Strength

Despite structural and political challenges, the U.S. possesses significant scientific advantages:

•Rapid Medical Countermeasures: Thanks to organizations like BARDA (Biomedical Advanced Research and Development Authority) and initiatives like Project NextGen, the U.S. has robust pipelines for developing vaccines and therapeutics. If a known threat like H5N1 avian flu were to jump to humans, candidate seed vaccines and manufacturing protocols are already established.

•Advanced Surveillance Tools: The U.S. has successfully scaled up domestic wastewater monitoring, which acts as a highly effective, passive early-warning system for detecting pathogens in communities before clinical cases spike.

•Private-Sector Adaptability: The COVID-19 pandemic forged strong supply-chain and manufacturing partnerships between the federal government and private pharmaceutical/diagnostic companies. This framework can be reactivated to scale up testing and treatments rapidly.

Summary

The United States has the best scientific tools, medical countermeasures, and laboratory technology in its history to fight a pandemic. However, its delivery systems are compromised. Slashed funding, a depleted public health workforce, isolation from international surveillance networks (due to the WHO withdrawal), and deep political polarization over medical interventions mean that if a novel, highly lethal pathogen begins spreading, the U.S. remains highly vulnerable to a fragmented, sluggish, and uncoordinated response.

Citations (24)

1theguardian.comNews and mediaquality 0.75
theguardian.com
Backs: “While the U.S. possesses unprecedented medical technologies and scientific tools developed since COVID-19, its public health infrastructure, global surveillance networks, and institutional trust have experienced significant shifts and disruptions.”
2bu.eduAcademic
bu.edu
Backs: “While the U.S. possesses unprecedented medical technologies and scientific tools developed since COVID-19, its public health infrastructure, global surveillance networks, and institutional trust have experienced significant shifts and disruptions.”
3cbsnews.comNews and mediaquality 0.88
cbsnews.com
Backs: “While the U.S. possesses unprecedented medical technologies and scientific tools developed since COVID-19, its public health infrastructure, global surveillance networks, and institutional trust have experienced significant shifts and disruptions.”
4tandfonline.comAcademic
tandfonline.com
Backs: “The consensus among public health experts, independent watchdogs, and policy analysts is that the U.S. remains highly vulnerable and, in several key areas, is less prepared to respond to a major outbreak than it was prior to 2020.”
5newrepublic.comNews and mediaquality 0.56
newrepublic.com
Backs: “Kennedy Jr., the federal government has heavily prioritized addressing chronic diseases and environmental toxins through the "Make America Healthy Again" (MAHA) initiative.”
6hhs.govGovernment
hhs.gov
Backs: “Kennedy Jr., the federal government has heavily prioritized addressing chronic diseases and environmental toxins through the "Make America Healthy Again" (MAHA) initiative.”
7hhs.govGovernment
hhs.gov
Backs: “Kennedy Jr., the federal government has heavily prioritized addressing chronic diseases and environmental toxins through the "Make America Healthy Again" (MAHA) initiative.”
8americanoversight.orgNonprofits and think tanks
americanoversight.org
Backs: “However, this shift has also come with deep skepticism toward traditional vaccine mandates, changes to federal advisory committees, and proposals to scale back infectious disease research.”
9medpagetoday.comNews and mediaquality 0.94
medpagetoday.com
Backs: “However, this shift has also come with deep skepticism toward traditional vaccine mandates, changes to federal advisory committees, and proposals to scale back infectious disease research.”
10thinkglobalhealth.orgNonprofits and think tanks
thinkglobalhealth.org
Backs: “The White House Pandemic Office (OPPR): The Office of Pandemic Preparedness and Response Policy (OPPR), created by Congress in 2022 to coordinate cross-agency responses, sat empty and unstaffed for nearly a year after Biden-era staff departed and a previous director resigned.”
11wikipedia.orgEncyclopedias and referencequality 0.83
wikipedia.org
Backs: “The White House Pandemic Office (OPPR): The Office of Pandemic Preparedness and Response Policy (OPPR), created by Congress in 2022 to coordinate cross-agency responses, sat empty and unstaffed for nearly a year after Biden-era staff departed and a previous director resigned.”
12beckershospitalreview.comNews and mediaquality 0.49
beckershospitalreview.com
Backs: “Rachel Idowu as National Security Council (NSC) director for bioresponse.”
13notus.orgNot yet classified
notus.org
Backs: “Rachel Idowu as National Security Council (NSC) director for bioresponse.”
14notus.orgNot yet classified
notus.org
Backs: “Critics note that the office remains vastly understaffed compared to its peak, leaving its capability to coordinate a massive interagency response in question.”
15cdc.govGovernment
cdc.gov
Backs: “The WHO Withdrawal: On January 22, 2026, the United States formally finalized its withdrawal from the World Health Organization (WHO), terminating federal funding and recalling all personnel.”
16cdc.govGovernment
cdc.gov
Backs: “The WHO Withdrawal: On January 22, 2026, the United States formally finalized its withdrawal from the World Health Organization (WHO), terminating federal funding and recalling all personnel.”
17umn.eduAcademic
umn.edu
Backs: “Global health experts warn this is a critical blow to U.S. preparedness, as the U.S. no longer participates in the Global Influenza Surveillance and Response System (GISRS).”
18tfah.orgNonprofits and think tanks
tfah.org
Backs: “According to the Ready or Not 2026 report published by the nonpartisan Trust for America's Health (TFAH), state-level emergency preparedness is highly uneven: Only 20 states placed in the high-performance tier for emergency readiness, while 17 states (plus D.C.) were in the middle tier, and 13 states fell into the…”
19nphic.orgNot yet classified
nphic.org
Backs: “According to the Ready or Not 2026 report published by the nonpartisan Trust for America's Health (TFAH), state-level emergency preparedness is highly uneven: Only 20 states placed in the high-performance tier for emergency readiness, while 17 states (plus D.C.) were in the middle tier, and 13 states fell into the…”
20tfah.orgNonprofits and think tanks
tfah.org
Backs: “According to the Ready or Not 2026 report published by the nonpartisan Trust for America's Health (TFAH), state-level emergency preparedness is highly uneven: Only 20 states placed in the high-performance tier for emergency readiness, while 17 states (plus D.C.) were in the middle tier, and 13 states fell into the…”
21policycommons.netNot yet classified
policycommons.net
Backs: “Additionally, federal funding cuts and administrative instability at the national level have trickled down, destabilizing local health departments and reducing the overall public health workforce.”
22halyardhealth.comCompanies
halyardhealth.com
Backs: “Pockets of vaccine hesitancy have contributed to preventable domestic outbreaks, such as measles. Workforce Exhaustion and Brain Drain: The public health and healthcare sectors have suffered immense burnout since the COVID-19 pandemic.”
23aspr.govGovernment
aspr.gov
Backs: “Areas of Scientific and Technological Strength. Despite structural and political challenges, the U.S. possesses significant scientific advantages: Rapid Medical Countermeasures: Thanks to organizations like BARDA (Biomedical Advanced Research and Development Authority) and initiatives like Project NextGen, the U.S.…”
24cuny.eduAcademic
cuny.edu
Backs: “Private-Sector Adaptability: The COVID-19 pandemic forged strong supply-chain and manufacturing partnerships between the federal government and private pharmaceutical/diagnostic companies. This framework can be reactivated to scale up testing and treatments rapidly.”